Cite
Saito D, Kanazawa A, Shigihara N, et al. Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin. J Clin Med Res. 2017;9(3):193-199doi: 10.14740/jocmr2874w.
Saito, D., Kanazawa, A., Shigihara, N., Sato, F., Uchida, T., Sato, J., Goto, H., Miyatsuka, T., Ikeda, F., Ogihara, T., Ohmura, C., & Watada, H. (2017). Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin. Journal of clinical medicine research, 9(3), 193-199. https://doi.org/10.14740/jocmr2874w
Saito, Daisuke, et al. "Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin." Journal of clinical medicine research vol. 9,3 (2017): 193-199. doi: https://doi.org/10.14740/jocmr2874w
Saito D, Kanazawa A, Shigihara N, Sato F, Uchida T, Sato J, Goto H, Miyatsuka T, Ikeda F, Ogihara T, Ohmura C, Watada H. Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin. J Clin Med Res. 2017 Mar;9(3):193-199. doi: 10.14740/jocmr2874w. Epub 2017 Jan 25. PMID: 28179966; PMCID: PMC5289138.
Copy
Download .nbib